Go to deals
Healthcare

Alcidion (ASX:ALC) has acquired ExtraMed

Alcidion (ASX:ALC) has acquired ExtraMed Ltd., a UK provider of patient flow management software that helps address key pain-points for hospital administrative staff.

Alcidion is transforming healthcare with smart, intuitive and complementary software products and services that create a unique offering in the global healthcare market. It offers solutions that support interoperability, allow communication and task management, and deliver clinical decision support at the point-of-care to improve patient systems. Alcidion has delivered strong organic growth in FY20 (with solid revenue up 33% as of Q3). The acquisition of ExtraMed will further accelerate this growth profile. This will add nine NHS trusts (six being new to Alcidion), expanding its NHS presence to 27 trusts or ~19% of target Acute NHS market, with upside revenue potential on cross-sell opportunities for Miya (its flagship product).

ExtraMed is a long-standing UK market leader in patient flow and has a 20-year track record. It specializes in providing NHS trusts with software that helps frontline staff make informed decisions based on real-time visibility of patient flow.

Oaklins’ team in Australia acted as corporate advisor to the buyer in this transaction.

Parties

Talk to the deal team

 Scott  McInnes

Scott McInnes

Managing Director
Melbourne, Australia
Oaklins Henslow
 Sebastian  Bell

Sebastian Bell

Director
Sydney, Australia
Oaklins Henslow

Related deals

move UP has been acquired by Acture B.V.
Private Equity | Business Support Services | Healthcare

move UP has been acquired by Acture B.V.

move UP Gesellschaft für Gesundheitsmanagement mbH, an innovative provider of holistic corporate health management solutions, has been acquired by Acture B.V., a leader in welfare management. This acquisition represents a major step in Acture’s plans to expand into the German corporate health management sector.

Learn more
Sopharma Group has acquired two pharmaceutical products in Poland
Healthcare

Sopharma Group has acquired two pharmaceutical products in Poland

Sopharma Group has acquired Coffepirine and Kopiryna, two highly recognized medicines to treat headache. The acquisition will further expand the market presence of Sopharma Group in the Polish market and support the promising potential of the two pharmaceutical drugs.

Learn more
A group of Chilean investors has acquired Farmacias Ahumada
Consumer & Retail | Healthcare

A group of Chilean investors has acquired Farmacias Ahumada

A group of Chilean investors has acquired Farmacias Ahumada S.A. from Walgreens Boots Alliance.

Learn more